Deals 03 Oct 2016 Metavone seeks ASX listing Bookmark Save articles for future reference. Subscribe to BN Log In Share to Facebook X LinkedIn Perth-based biotechnology company Metavone hopes to list on the ASX next month after raising up to $5 million from investors in an initial public offering.
